Skip to content
Curevo VaccineCurevo Vaccine
  • About
    • About Us
    • Management Team
  • Programs
    • Amezosvatein for Shingles
    • Amezosvatein for Chickenpox
  • Contact Us

News

{"cpt":"blog","style":"3","columns":"3","show":"6","order":"DESC","orderby":"DESC"}
  • All
  • Events
  • News
  • Press Releases
  • Vaccines
26 May, 2026
Press Releases

Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention

by curevovaccine
02 Jun, 2025
Press Releases

Curevo Enrolls First Participants in Phase 2 Extension Trial

by curevovaccine
17 Mar, 2025
Press Releases

Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine

by curevovaccine
12 Jan, 2025
Press Releases

Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine

by curevovaccine
08 Jan, 2025
Press Releases

Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference

by curevovaccine
31 Oct, 2024
Press Releases

Curevo Presents Positive Shingles Vaccine Outcomes Data

by curevovaccine
1 2 3 4

News

Curevo Vaccine logo white 158x90

___________________

A wholly owned subsidiary of Eli Lilly and Company

Curevo Inc.
18911 N Creek Pkwy #150
Bothell, WA 98011

+1.206.492.5722

Terms of Use
Privacy Policy
Cookie Policy

Consumer Health Privacy Notice

 © 2026 Curevo Inc.® All rights reserved.